Evidence map›Paper›PMID 32354798›Full record

ArticleHeart (British Cardiac Society)2020

Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis.

Jia-Fu Wei, Fang-Yang Huang, Tian-Yuan Xiong, Qi Liu, Hong Chen, Hui Wang, He Huang, Yi-Chun Luo, Xuan Zhou, Zhi-Yue Liu and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Heart (British Cardiac Society), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed, 11 pooled it
4.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 11 syntheses or guidelines pooled it, 202 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Elevated plasma sTIM-3 levels in patients with severe COVID-19.The Journal of allergy and clinical immunology · 2021
    Trial
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 3 institutions in 2 countries.

Jia-Fu Wei *Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Fang-Yang Huang *Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.ORCID http://orcid.org/0000-0002-3049-2996
Tian-Yuan Xiong *Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Qi Liu *Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Hong Chen *The Public Health Clinical Center of Chengdu, Chengdu, Sichuan Province, China.
Hui Wang *Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
He HuangDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, China hmaochen@vip.sina.com weimi003@scu.edu.cn bernard.prendergast@gstt.nhs.uk huanghe@wchscu.cn.
Yi-Chun LuoDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Xuan ZhouDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Zhi-Yue LiuDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Yong PengDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Yuan-Ning XuDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Bo WangIntensive Care Unit, West China Hospital, Sichuan University, Chengdu, China.
Ying-Ying YangDepartment of Nephrology, West China Hospital, Sichuan University, Chengdu, China.
Zong-An LiangDepartment of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Xue-Zhong LeiCenter of Infectious Disease, West China Hospital, Sichuan University, Chengdu, China.
Yang GeDepartment of Functional Examination Room, The Public Health Clinical Center of Chengdu, Chengdu, Sichuan Province, China.
Ming YangDepartment of Respiratory Medicine, The Public Health Clinical Center of Chengdu, Chengdu, Sichuan Province, China.
Ling ZhangIntensive Care Unit, The Public Health Clinical Center of Chengdu, Chengdu, Sichuan Province, China.
Ming-Quan ZengIntensive Care Unit, The Public Health Clinical Center of Chengdu, Chengdu, Sichuan Province, China.
He YuCenter of Infectious Disease, West China Hospital, Sichuan University, Chengdu, China.
Kai LiuCenter of Infectious Disease, West China Hospital, Sichuan University, Chengdu, China.
Yu-Heng JiaDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Bernard D PrendergastDepartment of Cardiology, St Thomas' Hospital, London, UK hmaochen@vip.sina.com weimi003@scu.edu.cn bernard.prendergast@gstt.nhs.uk huanghe@wchscu.cn.ORCID http://orcid.org/0000-0002-6031-2124
Wei-Min LiDepartment of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China hmaochen@vip.sina.com weimi003@scu.edu.cn bernard.prendergast@gstt.nhs.uk huanghe@wchscu.cn.
Mao ChenDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, China hmaochen@vip.sina.com weimi003@scu.edu.cn bernard.prendergast@gstt.nhs.uk huanghe@wchscu.cn.
Sichuan University · CNPublic Health Clinical Center of Chengdu · CNSt Thomas' Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe sought to explore the prevalence and immediate clinical implications of acute myocardial injury in a cohort of patients with COVID-19 in a region of China where medical resources are less stressed than in Wuhan (the epicentre of the pandemic).

methodsWe prospectively assessed the medical records, laboratory results, chest CT images and use of medication in a cohort of patients presenting to two designated covid-19 treatment centres in Sichuan, China. Outcomes of interest included death, admission to an intensive care unit (ICU), need for mechanical ventilation, treatment with vasoactive agents and classification of disease severity. Acute myocardial injury was defined by a value of high-sensitivity troponin T (hs-TnT) greater than the normal upper limit.

resultsA total of 101 cases were enrolled from January to 10 March 2020 (average age 49 years, IQR 34-62 years). Acute myocardial injury was present in 15.8% of patients, nearly half of whom had a hs-TnT value fivefold greater than the normal upper limit. Patients with acute myocardial injury were older, with a higher prevalence of pre-existing cardiovascular disease and more likely to require ICU admission (62.5% vs 24.7%, p=0.003), mechanical ventilation (43.5% vs 4.7%, p<0.001) and treatment with vasoactive agents (31.2% vs 0%, p<0.001). Log hs-TnT was associated with disease severity (OR 6.63, 95% CI 2.24 to 19.65), and all of the three deaths occurred in patients with acute myocardial injury.

conclusionAcute myocardial injury is common in patients with COVID-19 and is associated with adverse prognosis.

Indexed as

BetacoronavirusAdultAge FactorsAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsBiomarkersCardiovascular AgentsChinaCohort StudiesCoronavirus InfectionsCOVID-19C-Reactive ProteinGlomerular Filtration RateHumansIntensive Care UnitsMiddle AgedAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsBiomarkersCardiovascular AgentsC-Reactive ProteinNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)Troponin Tmyocardial diseasesystemic inflammatory diseases

Identifiers

PMID32354798
PMCPMC7398466
OpenAlexW3023668196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.